| View |
|
DRP-264
|
Captopril
|
Biopril
|
25 mg
|
Tablet
|
Angiotensin-Converting Enzyme (ACE) Inhibitor
|
Drugmaker's Laboratories, Inc.
|
Philippines
|
Renewal
|
20 December 2023
|
22 March 2029
|
| View |
|
DR-XY47552
|
Azithromycin (as dihydrate)
|
Alzyl 500
|
500 mg
|
Film-Coated Tablet
|
-
|
Aurobindo Pharma Limited - Unit VII
|
India
|
Initial (Re-issuance)
|
16 August 2022
|
24 November 2026
|
| View |
|
DRP-7640-03
|
Trimetazidine Hydrochloride
|
Trimegen
|
35 mg
|
Monitored Release Tablet
|
Antiangina [Fatty Acid Oxidation (pFOX) Inhibitor]
|
Lloyd Laboratories, Inc.
|
Philippines
|
Automatic Renewal
|
20 February 2023
|
28 February 2028
|
| View |
|
DRP-5591-02
|
Metronidazole (as Benzoate)
|
Flazole
|
125 mg/5 mL
|
Oral Suspension
|
Antiprotozoal (Nitroimidazole Derivative)
|
Lloyd Laboratories, Inc.
|
Philippines
|
Renewal
|
23 March 2023
|
07 February 2028
|
| View |
|
DRP-6001
|
dl-Alpha Tocopheryl Acetate (Vitamin E)
|
E-Beryl
|
400 mg
|
Softgel Capsule
|
Vitamin
|
Curemed Healthcare Pvt. Ltd.
|
India
|
Renewal
|
12 June 2024
|
10 February 2030
|
| View |
|
DRP-3498
|
Carvedilol
|
Carbet
|
12.5 mg
|
Film-Coated Tablet
|
-
|
XL Laboratories Pvt. Ltd.
|
India
|
Automatic Renewal (Revalidation)
|
15 February 2022
|
13 January 2025
|
| View |
|
DRP-10791
|
Fexofenadine Hydrochloride
|
Fextallert-180
|
180mg
|
Film-Coated Tablet
|
-
|
Magbro Healthcare Pvt. Ltd.
|
India
|
Initial (Correction)
|
14 February 2023
|
24 November 2026
|
| View |
|
DRP-10792
|
Fexofenadine Hydrochloride
|
Fextallert-120
|
120 mg
|
Film-Coated Tablet
|
Antihistamine
|
Magbro Healthcare Pvt. Ltd.
|
India
|
Initial (Re-issuance) correction
|
08 November 2022
|
23 November 2026
|
| View |
|
DRP-6601-03
|
FOLIC ACID
|
ANFOL
|
5 mg
|
Capsule
|
ANTI-ANEMIC
|
J.M. Tolmann Laboratories, Inc.
|
Philippines
|
Renewal
|
09 October 2024
|
28 January 2030
|
| View |
|
DR-XY13374
|
Anemizent
|
Iron
|
15 mg (equivalent to 75 mg Ferrous Sulfate
Heptahydrate) / 0.6 mL
|
Syrup (Oral Drops)
|
-
|
San Marino Laboratories, Corporation
|
Philippines
|
-
|
24 November 2021
|
22 January 2025
|
| View |
|
DRP-5777
|
Dicycloverine Hydrochloride
|
Spasmoverin
|
10 mg/ 5 ml
|
Syrup
|
-
|
Drugmaker's Laboratories, Inc.
|
Philippines
|
-
|
24 November 2021
|
30 May 2025
|
| View |
|
DRP-5779
|
Prednisone
|
Systocor
|
5 mg
|
Tablet
|
Corticosteroid
|
Drugmaker's Laboratories, Inc.
|
Philippines
|
Renewal
|
02 November 2024
|
25 February 2030
|
| View |
|
DRP-5258
|
Amoxicillin (as Trihydrate)
|
Amorex
|
250 mg/5 mL
|
Powder For Suspension
|
Antibacterial (Penicillin)
|
Drugmaker's Laboratories, Inc.
|
Philippines
|
Renewal
|
02 November 2024
|
23 February 2030
|
| View |
|
DRP-10804
|
Escitalopram (as oxalate)
|
Intalopram 10
|
10 mg
|
Film-Coated Tablet
|
Antidepressant (Selective Serotonin Reuptake
Inhibitor)
|
Intas Pharmaceuticals Limited
|
India
|
Initial
|
29 November 2021
|
29 November 2026
|
| View |
|
DRP-10803
|
Escitalopram (as oxalate)
|
Intalopram 20
|
20 mg
|
Film-Coated Tablet
|
-
|
Intas Pharmaceuticals Limited
|
India
|
-
|
29 November 2021
|
29 November 2026
|
| View |
|
DR-XY 47568
|
Ticagrelor
|
None
|
60 mg
|
Film-Coated Tablet
|
Antithrombotic Agent (Platelet Aggregation Inhibitor)
|
Lloyd Laboratories, Inc.
|
Philippines
|
Monitored Release
|
29 November 2021
|
29 November 2024
|
| View |
|
DR-XY47569
|
Sitagliptin (as phosphate monohydrate) + Metformin
hydrochloride
|
None
|
50 mg/500 mg
|
Film-Coated Tablet
|
Combination of Oral Blood Glucose Lowering Drugs
|
Lloyd Laboratories, Inc.
|
Philippines
|
-
|
29 November 2021
|
29 November 2026
|
| View |
|
HRP-054-15
|
Ascorbic Acid
|
Convin-C
|
500 mg (equivalent to 562.43 mg Sodium Ascorbate)
|
Capsule
|
Vitamin
|
Compact Pharmaceuticals Corp.
|
Philippines
|
Renewal
|
29 July 2022
|
31 July 2028
|
| View |
|
DRP-8435
|
Phenylpropanolamine Hydrochloride
|
Nasathera P
|
6.25 mg/mL
|
Syrup (Oral Drops)
|
-
|
Morishita-Seggs Pharmaceuticals, Inc.
|
Philippines
|
-
|
24 November 2021
|
10 June 2025
|
| View |
|
BR-1381
|
Calfactant
|
Infasurf
|
35 mg/mL
|
Intratracheal Suspension
|
-
|
ONY Biotech Inc.
|
United States of America
|
Initial (correction)
|
29 July 2022
|
23 November 2026
|